慢性肾脏病与慢性高血压孕妇的妊娠结局:全国队列研究
该研究基于瑞典医学出生登记库1982-2012年2,788,490例单胎分娩,评估慢性高血压、慢性肾脏病及两者共存与不良妊娠结局的关联。结果显示三种情况均增加子痫前期、剖宫产、早产、小于胎龄儿和死产风险,且独立于年龄、BMI和产次,经产妇结局更差。
要点
- 慢性高血压者子痫前期风险最高(aOR 4.57),死产风险亦升高(aOR 1.65)。
- 慢性肾脏病者子痫前期风险aOR 2.05,医学指征早产风险升高,死产无显著关联。
- 两病共存者医学指征早产(aOR 9.09)和小于胎龄儿(aOR 4.52)风险最高。
核心结论
- 慢性高血压、慢性肾脏病或两者共存均增加不良妊娠结局风险,且独立于母亲年龄、BMI和产次。
- 经产妇在上述疾病背景下不良结局风险更高,应加强临床随访和多学科管理。
研究设计与样本
- 全国队列研究,使用瑞典医学出生登记库1982-2012年2,788,490例单胎分娩数据。
- 通过医学出生登记库和国家患者登记库识别慢性肾脏病和慢性高血压孕妇。
- 采用逻辑回归模型评估母亲慢性疾病与妊娠结局的关联。
主要发现
- 30年间,慢性肾脏病孕妇分娩22,397例(0.8%),慢性高血压13,279例(0.48%),两者共存1,079例(0.04%)。
- 慢性高血压与子痫前期关联最强(aOR 4.57,95%CI 4.33-4.84),与死产aOR 1.65(95%CI 1.35-2.03),与自发性早产关联最弱(aOR 1.07,95%CI 0.96-1.20)。
- 慢性肾脏病与医学指征早产aOR 2.05(95%CI 1.92-2.19),与死产无显著关联(aOR 1.16,95%CI 0.95-1.43)。
- 两病共存者剖宫产(aOR 1.86,95%CI 1.49-2.32)、医学指征早产(aOR 9.09,95%CI 7.61-10.7)和小于胎龄儿(aOR 4.52,95%CI 3.68-5.57)风险最高。
- 先天性肾脏病者子痫前期(aOR 3.98,95%CI 2.98-5.31)和死产(aOR 2.73,95%CI 1.13-6.59)风险最高;糖尿病肾病者剖宫产和小于胎龄儿风险最高;肾血管疾病者早产风险最高。
关键数值与推荐
- 慢性高血压:子痫前期aOR 4.57(95%CI 4.33-4.84),死产aOR 1.65(95%CI 1.35-2.03),自发性早产aOR 1.07(95%CI 0.96-1.20)。
- 慢性肾脏病:医学指征早产aOR 2.05(95%CI 1.92-2.19),死产aOR 1.16(95%CI 0.95-1.43)。
- 两病共存:产时剖宫产aOR 1.86(95%CI 1.49-2.32),术前剖宫产aOR 2.68(95%CI 2.18-3.28),医学指征早产aOR 9.09(95%CI 7.61-10.7),小于胎龄儿aOR 4.52(95%CI 3.68-5.57)。
- 先天性肾脏病:子痫前期aOR 3.98(95%CI 2.98-5.31),死产aOR 2.73(95%CI 1.13-6.59)。
- 糖尿病肾病:产时剖宫产aOR 3.54(95%CI 2.06-6.09),术前剖宫产aOR 7.50(95%CI 4.74-11.9),小于胎龄儿aOR 4.50(95%CI 2.92-6.94);肾血管疾病:自发性早产aOR 3.01(95%CI 1.57-5.76),医学指征早产aOR 8.09(95%CI 5.73-11.4)。
临床怎么用
- 对慢性高血压、慢性肾脏病或两者共存的孕妇应提供多学科管理及强化临床随访。
- 尤其关注经产妇,其不良妊娠结局风险更高。
- 根据肾脏病亚型评估子痫前期、早产、剖宫产和小于胎龄儿等风险,实施个体化监测。
局限性
- 需要进一步研究评估疾病严重程度对不良妊娠结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal chronic kidney disease and chronic hypertension have been linked with adverse pregnancy outcomes. We aimed to examine the association between these conditions and adverse pregnancy outcomes over the last 3 decades. OBJECTIVE: We conducted this national cohort study to assess the association between maternal chronic disease (CH, CKD or both conditions) and adverse pregnancy outcomes with an emphasis on the effect of parity, maternal age, and BMI on these associations over the last three decades. We further investigated whether different subtypes of CKD had differing effects. STUDY DESIGN: We used data from the Swedish Medical Birth Register, including 2,788,490 singleton births between 1982 and 2012. Women with chronic kidney disease and chronic hypertension were identified from the Medical Birth Register and National Patient Register. Logistic regression models were performed to assess the associations between maternal chronic disease (chronic hypertension, chronic kidney disease, or both conditions) and pregnancy outcomes, including preeclampsia, in-labor and prelabor cesarean delivery, preterm birth, small for gestational age, and stillbirth. RESULTS: During the 30-year study period, 22,397 babies (0.8%) were born to women with chronic kidney disease, 13,279 (0.48%) to women with chronic hypertension and 1079 (0.04%) to women with both conditions. Associations with chronic hypertension were strongest for preeclampsia (adjusted odds ratio, 4.57; 95% confidence interval, 4.33-4.84) and stillbirth (adjusted odds ratio, 1.65; 95% confidence interval, 1.35-2.03) and weakest for spontaneous preterm birth (adjusted odds ratio, 1.07; 95% confidence interval, 0.96-1.20). The effect of chronic kidney disease varied from (adjusted odds ratio, 2.05; 95% confidence interval, 1.92-2.19) for indicated preterm birth to no effect for stillbirth (adjusted odds ratio, 1.16; 95% confidence interval, 0.95-1.43). Women with both conditions had the strongest associations for in-labor cesarean delivery (adjusted odds ratio, 1.86; 95% confidence interval, 1.49-2.32), prelabor cesarean delivery (adjusted odds ratio, 2.68; 95% confidence interval, 2.18-3.28), indicated preterm birth (adjusted odds ratio, 9.09; 95% confidence interval, 7.61-10.7), and small for gestational age (adjusted odds ratio, 4.52; 95% confidence interval, 3.68-5.57). The results remained constant over the last 3 decades. Stratified analyses of the associations by parity, maternal age, and body mass index showed that adverse outcomes remained independently higher in women with these conditions, with worse outcomes in multiparous women. All chronic kidney disease subtypes were associated with higher odds of preeclampsia, in-labor cesarean delivery, and medically indicated preterm birth. Different subtypes of chronic kidney disease had differing risks; strongest associations of preeclampsia (adjusted odds ratio, 3.98; 95% confidence interval, 2.98-5.31) and stillbirth (adjusted odds ratio, 2.73; 95% confidence interval, 1.13-6.59) were observed in women with congenital kidney disease, whereas women with diabetic nephropathy had the most pronounced increase odds of in-labor cesarean delivery (adjusted odds ratio, 3.54; 95% confidence interval, 2.06-6.09), prelabor cesarean delivery (adjusted odds ratio, 7.50; 95% confidence interval, 4.74-11.9), and small for gestational age (adjusted odds ratio, 4.50; 95% confidence interval, 2.92-6.94). In addition, women with renovascular disease had the highest increased risk of preterm birth in both spontaneous preterm birth (adjusted odds ratio, 3.01; 95% confidence interval, 1.57-5.76) and indicated preterm birth (adjusted odds ratio, 8.09; 95% confidence interval, 5.73-11.4). CONCLUSION: Women with chronic hypertension, chronic kidney disease, or both conditions are at an increased risk of adverse pregnancy outcomes which were independent of maternal age, body mass index, and parity. Multidisciplinary management should be provided with intensive clinical follow-up to support these women during pregnancy, particularly multiparous women. Further research is needed to evaluate the effect of disease severity on adverse pregnancy outcomes.
引用
- Al Khalaf SY, O'Reilly ÉJ, McCarthy FP, et al. Pregnancy outcomes in women with chronic kidney disease and chronic hypertension: a National cohort study. Am J Obstet Gynecol. 2021. PMID: 33823152. doi:10.1016/j.ajog.2021.03.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。